Skip to main content

VITROLIFE AB Value Stock - Dividend - Research Selection

Vitrolife AB

ISIN: SE0011205202, WKN: A2JLT3

Market price date: 18.01.2022
Market price: 379,80 SEK


Vitrolife AB Fundamental data and company key figures of the share

Annual reports in SEK
Key figures 28-09-2021
Cash flow
Net operating cash flow 356.448.000
Capital Expenditures -6.769.000
Free cash flow 349.679.008
Balance sheet
Total Equity 2.012.570.000
Liabilities & Shareholders equity 2.305.090.000
Income statement
Net income 286.846.000
Eps (diluted) 2,643
Diluted shares outstanding 108.551.000
Net sales/revenue 1.245.570.000

Fundamental ratios calculated on: 18-01-2022

Ratios
Key figures 18-01-2022
Cash flow
P/C 115,66
   
P/FC 117,90
Balance sheet
ROI12,44
ROE87,31
Income statement
P/E143,73
Div. Yield0,21%
P/B20,49
P/S33,10


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolVITR.ST
Market Capitalization4.649.195.520,00 USD
CountrySweden
IndicesSTOXX EUROPE 600
SectorsBiotechnology
Raw Data SourceIFRS in Millionen SEK
Stock Split2018-05-17,5.000000/1.000000
Internetwww.vitrolife.com


Description of the company

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It offers oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also provides EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.vitrolife.com


NEWS